Merck (Biosimilars Business) Overview

  • Founded

  • 2012

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 70

Employees
  • Latest Deal Type

  • M&A

  • Financing Rounds

  • 1

Merck (Biosimilars Business) General Information

Description

Provider of generic drugs intended to offer drugs to oncology and inflammatory disorders. The company's generic drugs include biologics manufacturing facilities enabling drug companies to provide drugs to the patients suffering from oncology and inflammatory disorders.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Acquirer
Fresenius Kabi USA
Primary Office
  • Frankfurter Straße 250
  • 64293 Darmstadt
  • Germany

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Merck (Biosimilars Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Merck (Biosimilars Business)‘s full profile, request access.

Request a free trial

Merck (Biosimilars Business) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Merck (Biosimilars Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Merck (Biosimilars Business)‘s full profile, request access.

Request a free trial